Companies / Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc.

Nasdaq: KYTXCIK 1994702EMERYVILLE, CA

Financials

Revenue—
Net income$-161.31M
Total debt$24.88M
Cash$31.81M
Diluted EPS$-3.64
Shares outstanding61.8M

Ownership

61.8M shares outstanding · as of Aug 3, 2026
0.39%Insiders
Ownership
Insiders0.39%244,128
Institutions63.80%39,458,330
Public float35.80%22,140,986

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 10

View all →
Insider% of sharesShares
Shaw ChristiExecutive Chairperson · Director
0.11%70,935
Biddle Warner WestonCEOChief Executive Officer · Director
0.09%58,000
Clark Ian TDirector
0.04%21,727
Cohen Fred EDirector
0.04%21,727
Seidenberg Beth CDirector
0.04%21,727
Gehchan NajiSee Remarks
0.03%18,000
Emany Sravan KumarDirector
0.02%11,006
Miller Andrew CraigDirector
0.02%11,006
Grasso MarcChief Financial Officer
0.02%10,000
Pujols MayobanexChief Technology Officer
——

Institutional holders 107

View all →
HolderValue% of shares
GordonMD Global Investments LP$41.28M7.10%
Gilead Sciences, Inc.$38.79M6.67%
Bain Capital Life Sciences Investors, LLC$29.23M5.03%
BlackRock, Inc.$27.93M5.07%
AIGH Capital Management LLC$24.91M4.52%
Deerfield Management Company, L.P.$17.26M3.23%
Vanguard Group Inc$16.74M2.88%
Balyasny Asset Management L.P.$9.71M1.82%
Morgan Stanley$9.42M1.62%
State Street Corporation$8.75M1.59%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
May 27, 2026Cohen Fred E
Director
GrantCommon Stock$0+5K
+30.62%
21,727
0.04% of shares
low
May 27, 2026Clark Ian T
Director
GrantCommon Stock$0+5K
+30.62%
21,727
0.04% of shares
low
May 27, 2026Seidenberg Beth C
Director
GrantCommon Stock$0+5K
+30.62%
21,727
0.04% of shares
low
Mar 13, 2026Gehchan Naji
Executive
GrantCommon Stock$0+18K
18,000
0.03% of shares
low
Mar 13, 2026Biddle Warner Weston
CEO
GrantCommon Stock$0+58K
58,000
0.09% of shares
low
Feb 24, 2026Emany Sravan Kumar
Director
GrantCommon Stock$0+11K
11,006
0.02% of shares
low
Feb 24, 2026Miller Andrew Craig
Director
GrantCommon Stock$0+11K
11,006
0.02% of shares
low
Mar 13, 2026Grasso Marc
Executive
GrantCommon Stock$0+10K
10,000
0.02% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Westlake BioPartners Fund I, L.P. ("Westlake Fund I")Passive13G/A———
Bain Capital Life Sciences Opportunities III, LPPassive13G/A———
Northpond Ventures III, LPPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
KYTXCommon StockEquity501976104BBG00RCYMHR1